Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability — PrevHPV  

HPV Vaccine Acceptability Clinical Trial

Official title: Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability Among French Adolescents: a Cluster Randomized Controlled Trial

Status Completed

Clinical Trial Summary

This study aims at evaluating the effectiveness, efficiency and implementation of a multicomponent intervention (components being applied in combination or alone) on the acceptability of HPV vaccine among French adolescents (11-14 years old) through a cluster randomized controlled trial. The primary outcome to measure acceptability is vaccine coverage. The three components are: adolescents and parents' education and motivation at school (component 1); general practitioners' training (component 2); and access to vaccination at school (component 3). Ninety municipalities are included and randomized into six groups of 15 municipalities, according an incomplete factorial plan.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• HPV Vaccine Acceptability

• NCT number: NCT04945655
• Study type: Interventional
• Source: Institut National de la Santé Et de la Recherche Médicale, France
• Status: Completed
• Phase: N/A
• Start date: November 15, 2021
• Completion date: April 30, 2023